Types of Eczema: 7+ Forms, Causes, and How to Tell Them Apart

What Is Eczema? Understanding the Umbrella Term

Eczema is not a single disease. It is a group of inflammatory skin conditions that share a common set of symptoms: itching, redness, dryness, and a disrupted skin barrier. Dermatologists recognize at least seven major subtypes, and some classification systems identify even more when you include variants like asteatotic eczema and infective dermatitis.^[3]

What unites every form of eczema under one umbrella? A shared pattern visible under the microscope. When a dermatologist biopsies any type of eczema, the tissue almost always shows spongiotic dermatitis, a pattern of fluid accumulation between skin cells in the epidermis that causes the characteristic swelling and itch.^[4] This histological fingerprint confirms that despite their different triggers and locations, all eczema types share a common inflammatory pathway.

Globally, atopic dermatitis alone affected 171 million people in 2019, roughly the population of Bangladesh, a 28.6% rise from 1990, with the highest rates in children aged 5 to 9.^[1] Those numbers have been climbing steadily in industrialized nations over the past three decades.^[5] Understanding which type you have is the first step toward breaking the cycle of ineffective treatment.

Eczema vs. Dermatitis: Is There a Difference?

You will see both words used, sometimes together. Here is the simple truth: in modern dermatology, "eczema" and "dermatitis" mean the same thing. "Dermatitis" comes from Greek (derma = skin, itis = inflammation). "Eczema" comes from a Greek word meaning "to boil over," describing the weeping, blistering appearance of acute flares.

Some textbooks reserve "eczema" for endogenous (internally driven) types and "dermatitis" for exogenous (externally triggered) types. In practice, most clinicians use the terms interchangeably. "Atopic dermatitis" and "atopic eczema" describe the same condition. So do "contact dermatitis" and "contact eczema." Do not let the terminology confuse you. Focus on the subtype, not the label.

The Major Types of Eczema at a Glance

Before diving into the details, here is a side-by-side snapshot of every major type. This table covers the hallmark feature, typical location, age of onset, and primary driver for each form of eczema. For a visual walkthrough with images, see our complete visual guide to different types of eczema.

The practical takeaway: your eczema type determines your treatment strategy. A moisturizer that calms atopic dermatitis may do nothing for contact dermatitis if the allergen is still present.

Endogenous Types: Eczema That Starts from Within

Endogenous eczema types arise from internal factors: your genetics, your immune system, or your body's own chemistry. You cannot "catch" these forms of eczema from someone else, and you cannot always avoid them by changing your environment. What you can do is understand the mechanism driving each one, so you can target it directly.

Atopic Dermatitis: The Most Common Form

Atopic dermatitis is the most common type of eczema by a wide margin. In one large multicenter study of more than 8,000 patients, it was the leading specified subtype, accounting for 13.4% of all eczema diagnoses.^[3] If someone says "I have eczema" without specifying a type, they almost always mean atopic dermatitis. Think of itchy patches behind a toddler's knees, or the rash that flares on the inner elbows every winter, those are the classic signatures.

The root cause involves two intertwined problems. The first is a defective skin barrier, often traced to mutations in the filaggrin gene, which weakens the outermost layer of skin like mortar crumbling between bricks.^[35] You can explore this in our guide to the root causes of atopic dermatitis. The second is an overactive immune response: once the barrier is compromised, skin cells (keratinocytes) release alarm signals (cytokines such as TSLP, IL-25, and IL-33) that switch on Th2 immune cells, fueling the type 2 inflammation behind the chronic itch and redness.^[14]

Genetics alone do not explain the rapid rise in prevalence. Frequency of atopic dermatitis ranged from 1.1% to 3.1% in populations born before 1960, then climbed to 12% by 1974 in industrialized countries.^[5] When East and West Germany reunified, AD prevalence in the East caught up with the West within ten years.^[5] Environmental factors, including reduced microbial exposure in early life, play a significant role. For a deeper look at how your DNA shapes your skin, see our guide to eczema and genetics.

You will typically see atopic dermatitis in the flexural folds (the inner elbows, behind the knees, the neck, and the wrists), and in infants it often starts on the cheeks and scalp. The hallmark is intense, relapsing itch, the kind that wakes a child at 2 a.m. and disrupts sleep in 47% to 80% of pediatric patients. For a broader look at how eczema symptoms present across types and severity levels, see our guide to eczema symptoms.^[15] For a deep dive into treatment options, explore our guide to atopic dermatitis treatments.

Seborrheic Dermatitis: Yeast-Driven Inflammation

Seborrheic dermatitis targets areas rich in oil glands: the scalp, eyebrows, nasolabial folds, and chest. It affects 1 to 3% of the general adult population, but prevalence jumps to 30 to 83% in people with HIV.^[10]

The driving force is Malassezia, a yeast that lives harmlessly on nearly everyone's skin. In susceptible people, this yeast breaks down the natural oils (sebum) on the skin and releases fatty acids like oleic acid, which irritate the skin and disrupt its barrier, similar to how a small drop of vinegar can curdle milk. To understand what drives these flares, see our guide to what causes seborrheic dermatitis.^[16]

• In infants: Seborrheic dermatitis appears as "cradle cap," hard scaly patches on a red inflamed base with white or yellow scale. Point prevalence in the first three months of life is 71.7%, dropping to less than 1% by age three.^[17]
• In adults: It is chronic or relapsing, worsening with stress, sleep deprivation, and winter weather, and improving in summer.^[10]

Learn more in our detailed guide to seborrheic dermatitis causes, symptoms, and treatments.

Nummular Eczema: Coin-Shaped Lesions

Nummular eczema (also called discoid eczema) produces distinctive coin-shaped plaques that set it apart from every other eczema type. These round or oval patches appear most often on the extremities, particularly the legs, and can be intensely itchy.^[9]

This type shows a bimodal age distribution. Men typically develop it later in life, while women get it at a younger age.^[9] Dry skin is the most consistent trigger, and an impaired epidermal barrier may allow allergen permeation. Bacterial colonization can also play a role: in a study of 123 nummular eczema patients, Staphylococcus was the most frequent pathologic finding on nose and throat swabs (14.6%), and antibiotic treatment improved skin findings in some cases.^[18]

Nummular eczema often gets misdiagnosed as ringworm because both produce round patches.^[9] A potassium hydroxide test or fungal culture can rule out fungal infection. For a complete breakdown, see our guide on nummular eczema.

Dyshidrotic Eczema: Blisters on Hands and Feet

Dyshidrotic eczema (also called pompholyx) produces deep-seated, intensely itchy vesicles on the palms, soles, and sides of the fingers, tiny clear blisters that feel like tapioca pearls embedded under the skin. In one study of 175 hand dermatitis patients, 42.3% presented with this pattern, with lesions on the palms in 75.4% and on the feet in 36.0%.^[8]

Hand dermatitis usually begins in the third decade of life.^[8] Triggers include nickel and cobalt sensitivity, emotional stress, and atopy. In patch testing of hand eczema patients, nickel sulfate (33%) and cobalt chloride (12%) were among the most common relevant allergens.^[19] Many patients with dyshidrotic eczema also have atopic dermatitis, highlighting how eczema types frequently overlap.^[8]

Explore the full picture in our guide to dyshidrotic eczema and how it is treated.

Asteatotic Eczema and Spongiotic Dermatitis on Biopsy

Asteatotic eczema (eczema craquelé) looks like cracked porcelain. It develops when skin becomes extremely dry, forming a network of fine fissures surrounded by redness. You see it most often on the shins of elderly patients during winter months, when low humidity and indoor heating strip moisture from the skin.^[3]

Spongiotic dermatitis deserves special mention because it often appears on biopsy reports and causes confusion. It is not a separate type of eczema. It is the histological pattern that all eczema types share. In a pediatric biopsy study, spongiotic/psoriasiform dermatitis was the most common inflammatory pattern (38%), frequently including atopic/allergic dermatitis.^[4] If your biopsy report says "spongiotic dermatitis," it confirms you have some form of eczema. Your dermatologist then determines which type based on clinical features.

Exogenous Types: Eczema Triggered by External Factors

Exogenous eczema types start from the outside in. Something in your environment, whether a chemical at work, an allergen in your jewelry, poor blood flow in your legs, or even your own scratching, triggers the inflammation. The good news is that once you remove or manage the external factor, you can often control the condition. But first, you need to identify it.

Contact Dermatitis: Allergic and Irritant Forms

Contact dermatitis is the second most common group of eczema types after atopic dermatitis. It comes in two distinct forms, and telling them apart matters for treatment.

Allergic contact dermatitis (ACD) accounts for roughly 20% of contact dermatitis cases. Think of it as your immune system holding a grudge: once it has been sensitized to a substance, it remembers, and the next time you encounter that allergen, specialized immune cells launch an inflammatory response within 24 to 48 hours.^[6] The most common culprits identified through scalp patch testing include nickel (23.8%), cobalt (21.0%), balsam of Peru (18.2%), and fragrance mix (14.4%).^[20] For a full list of ingredients that can trigger reactions, see our guide to the worst ingredients for eczema.

Irritant contact dermatitis (ICD) does not involve immune sensitization. It accounts for roughly 80% of all contact dermatitis cases.^[7] Repetitive occlusion, maceration, and disruption of the skin barrier directly damage the tissue. Wet work is the most common cause of occupational hand dermatitis, with healthcare workers, hairdressers, and metal workers at highest risk. According to CDC data, 90 to 95% of occupational skin diseases are contact dermatitis, and up to 80% of those cases involve the hands.^[21]

For more on irritant dermatitis in daily life, read our article on shaving rash and irritant dermatitis.

Stasis Dermatitis: Circulation-Related Eczema

Stasis dermatitis stands apart from every other eczema type because its root cause is poor circulation, not the immune system or an allergy. It develops when weakened leg veins (chronic venous insufficiency) let blood pool in the lower legs, much like water backing up behind a clogged drain. The pressure forces red blood cells out into the surrounding tissue, where they leave behind iron deposits that give the skin its characteristic brownish stain, along with inflammation and hardening.^[11]

You will see stasis dermatitis on the lower legs and ankles in adults over 50: reddish-brown discoloration, swelling that worsens by evening (you may notice socks leaving deep marks by dinnertime), and skin that gradually becomes thickened and leathery.^[11] Left untreated, it can progress to venous leg ulcers, which affect up to 2% of the population (and 5% of those over 65) and recur in 50 to 70% of cases.^[11] For Dr. Harlan's clinical protocol, see the stasis dermatitis treatment guide.

Treatment must address the underlying venous problem. Compression therapy is the cornerstone, reducing edema and improving tissue oxygenation. In a randomized trial, intermittent pneumatic compression significantly reduced ankle circumference and improved tissue oxygen saturation in stasis dermatitis patients.^[22] Topical corticosteroids manage the dermatitis component, with clinical improvement typically noted within 7 to 10 days when combined with compression and skin care.^[23] Learn more in our guide to stasis dermatitis.

Neurodermatitis: The Itch-Scratch Cycle

Neurodermatitis (also called lichen simplex chronicus) is driven by a behavior that feeds itself: scratching. It usually starts with a minor itch from irritation or stress, but the scratching damages the skin, which releases chemical signals that activate immune cells and ramp up the itch nerves, creating what researchers call a "vicious circle of itch and scratch."^[12] It is the skin equivalent of picking at a scab that never quite heals. Over time, the affected patch becomes thick, leathery, and darker than the surrounding skin.

Neurodermatitis affects an estimated 12% of the general population, roughly 1 in 8 people, and is particularly prevalent in middle-aged patients aged 30 to 50, with women affected twice as often as men. For a complete clinical overview, see our dedicated guide to neurodermatitis causes, symptoms, and treatment.^[12] Roughly 20 to 90% of those affected report a personal or family history of atopic conditions.^[12] Psychosocial stress is a strong driver, with significantly higher rates of psychiatric comorbidities like depression and anxiety.^[12] For Dr. Harlan's treatment protocol, see the neurodermatitis SmartLotion guide, and to understand the stress connection more broadly, read our article on stress and eczema.

When Types Overlap: The Diagnostic Challenge

Here is where things get complicated. Eczema types do not always stay in neat categories. Many patients have two or more types at the same time, and some body areas attract overlapping forms that look nearly identical on the surface. For a location-by-location breakdown, see our guide to eczema on the body.

Hand Eczema: Where Multiple Types Converge

Hand eczema is the perfect example of diagnostic overlap, because "hand eczema" describes a location, not a type. The eczema on your hands could be atopic, dyshidrotic, allergic contact, irritant contact, or a combination of several. A large Dutch study of nearly 58,000 people found that about 1 in 7 will have hand eczema at some point in life (a lifetime prevalence of 15.0%), with 7.3% experiencing it in any given year.^[24]

Consider a nurse with atopic dermatitis who develops irritant contact dermatitis from frequent handwashing, then becomes sensitized to latex gloves. She now has three overlapping types on the same pair of hands. In a retrospective study of 173 hand eczema patients undergoing patch testing, 61.8% had ICD, 56.6% had ACD, and 23.1% had AD, with overlapping diagnoses in 42.8% of patients.^[19]

This is why patch testing is so valuable. Identifying and removing a contact allergen can dramatically improve outcomes even when other eczema types are also present. For practical strategies, see our guide to hand eczema causes and treatments.

Eczema vs. Psoriasis: Telling Them Apart

The eczema-psoriasis distinction trips up patients and clinicians alike. Both cause red, scaly patches, and both can appear on similar body areas. In rare cases, patients have both conditions simultaneously, an overlap syndrome documented in clinical case series.^[25]

For a thorough comparison, read our dedicated article on the difference between psoriasis and eczema.

Treatment Principles Across All Types of Eczema

Despite their different triggers and mechanisms, all eczema types share a disrupted skin barrier and an inflammatory component. That means a core treatment framework applies across the board, with type-specific additions layered on top.

Emollient therapy is the non-negotiable foundation for every type of eczema. For guidance on choosing the right product for your skin, see our article on what cream is good for eczema. Regular and liberal use of moisturizers (roughly 600 grams per week for an adult) is recommended as baseline therapy, and consistent use can prolong flare-free periods while reducing the need for anti-inflammatory treatment.^[28] But not all emollients are equal. A randomized trial comparing different formulations found that urea-glycerol cream significantly reduced transepidermal water loss and protected against irritant-induced damage, while simple paraffin cream had no effect on barrier function.^[28] For a science-backed breakdown, see our guide on how moisturizers work and their key ingredients.

When moisturizing alone is not enough, anti-inflammatory treatments step in. Over-the-counter options include low-potency hydrocortisone (1%) for mild flares and colloidal oatmeal preparations. HarlanMD developed SmartLotion, an effective eczema cream that combines a very low concentration of hydrocortisone with prebiotic support for the skin microbiome, addressing both inflammation and barrier disruption in one OTC product.^[36]

Prescription topicals form the next rung. Topical corticosteroids come in low, medium, high, and very high potency formulations matched to severity, but ideally limited to intermittent short-term use to avoid local adverse effects like skin atrophy.^[30] Topical calcineurin inhibitors (tacrolimus, pimecrolimus) offer a noncorticosteroid alternative, particularly valuable for sensitive areas like the face, neck, and eyelids where corticosteroid use risks telangiectasia and, around the eyes, glaucoma. For location-specific guidance on treating facial eczema safely, see our facial eczema treatment guide.^[31]

For moderate-to-severe atopic dermatitis that fails topical treatment, systemic and biologic options become appropriate. In a 5-year open-label extension study, 88.9% of adults on dupilumab achieved 75% or greater improvement in eczema severity (EASI-75), and 67.5% reached IGA scores of 0 or 1 (clear or almost clear) at week 260.^[32] JAK inhibitors like upadacitinib, abrocitinib, and baricitinib have also shown superior efficacy to placebo in network meta-analyses.^[33] For a full overview, see our guide to atopic dermatitis treatments. You can also explore the full range of options in our comprehensive eczema treatment guide.

The practical takeaway: the best treatment plan layers foundational moisturizing with the right level of anti-inflammatory therapy for your severity, regardless of which eczema type you have.

How to Identify Your Type of Eczema

Knowing the types of eczema with pictures and descriptions helps you narrow down the possibilities, but self-diagnosis has real limits. Even clinical diagnosis can miss the mark: in one analysis of suspected mycosis fungoides, false-negative and false-positive reporting rates between clinical and histological findings reached as high as 40%, and eczema-like conditions were often the alternate diagnosis.^[34] If trained dermatologists can be wrong nearly half the time on certain look-alikes, the gap widens further for non-specialists.

Start with these four questions to guide your thinking:

• Where is it? Flexural folds suggest atopic dermatitis. Lower legs point to stasis dermatitis. Scalp and face suggest seborrheic dermatitis. Hands could be almost anything.
• What does it look like? Coin-shaped patches suggest nummular eczema. Tiny blisters on palms suggest dyshidrotic eczema. Greasy yellow scales suggest seborrheic dermatitis.
• When did it start and what makes it worse? Childhood onset with family history of allergies points to atopic dermatitis. Onset after starting a new job suggests occupational contact dermatitis. For a deeper look at how eczema changes across life stages, see our guide to eczema by age group.^[21]
• Do you have other atopic conditions? Asthma, hay fever, or food allergies alongside eczema strongly suggest the atopic subtype. To understand how diet and food sensitivities interact with eczema, see our guide on diet and eczema.^[14]

Frequently Asked Questions About Types of Eczema

How many types of eczema are there?

Dermatologists recognize at least seven major types: atopic dermatitis, allergic contact dermatitis, irritant contact dermatitis, dyshidrotic eczema, nummular eczema, seborrheic dermatitis, and stasis dermatitis. Large classification studies also list neurodermatitis, asteatotic eczema, photo-contact dermatitis, autosensitization eczema, and widespread eczema, bringing the total to a dozen or more named subtypes.^[3]

What is the most common type of eczema?

Atopic dermatitis is by far the most common type. In a multicenter study of more than 8,000 outpatients, it accounted for 13.4% of all diagnoses, ahead of irritant contact dermatitis (9.2%) and widespread eczema (8.7%).^[3] Globally, atopic dermatitis affects 171 million people.^[1]

Can you have more than one type of eczema?

Yes. In a study of hand eczema patients undergoing patch testing, 42.8% had overlapping diagnoses (commonly ICD plus ACD, sometimes with atopic dermatitis layered on top).^[19] Many patients with dyshidrotic eczema also have atopic dermatitis.^[8]

Is eczema the same as dermatitis?

In modern clinical practice, yes. The terms are used interchangeably. "Dermatitis" literally means skin inflammation, and "eczema" describes the same group of conditions. Some older textbooks distinguish between them, but most dermatologists today treat the words as synonyms.

Which type of eczema is the most severe?

Any type can range from mild to severe. Atopic dermatitis has the widest severity spectrum and is most likely to require systemic therapy or biologics. For a complete look at how eczema presents and is managed across all age groups, see our guide to eczema by age group.^[32] Stasis dermatitis can also become severe when it progresses to venous leg ulcers, which carry a 50 to 70% recurrence rate.^[11] Severity depends more on individual factors than on the type itself.

References

1. Shin YH, Hwang J, Kwon R, Lee SW, Kim MS, Shin JI, Yon DK; GBD 2019 Allergic Disorders Collaborators. "Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019." Allergy. 2023. View Study
2. Jacob SE, Scheman A, Nedorost S. "Reframing Eczema: Th2-Skewed Contact Sensitization, Atopy Patch Testing, and Systemic Contact Dermatitis." Current Allergy and Asthma Reports. 2026. View Study
3. Wang X, Shi XD, Li LF, Zhou P, Shen YW. "Classification and possible bacterial infection in outpatients with eczema and dermatitis in China: A cross-sectional and multicenter study." Medicine (Baltimore). 2017. View Study
4. Calım-Gurbuz B, Pehlıvanoglu B, Soylemez-Akkurt T, Erdem O, Ahmedov A. "Skin Lesions in Children: Evaluation of Clinicopathological Findings." Turk Patoloji Derg. 2023. View Study
5. Kıykım A, Öğülür İ, Yazıcı D, Çokuğraş H, Akdiş M, Akdiş CA. "Epithelial Barrier Hypothesis and Its Comparison with the Hygiene Hypothesis." Turkish Archives of Pediatrics. 2023. View Study
6. Tramontana M, Hansel K, Bianchi L, Sensini C, Malatesta N, Stingeni L. "Advancing the understanding of allergic contact dermatitis: from pathophysiology to novel therapeutic approaches." Frontiers in Medicine. 2023. View Study
7. Cichoń M, Trzeciak M, Sokołowska-Wojdyło M, Nowicki RJ. "Contact Dermatitis to Diabetes Medical Devices." International Journal of Molecular Sciences. 2023. View Study
8. Endlich LRFG, Samorano LP, Nunes RS, Reis VMS. "Hand dermatitis: a 6-year experience in a tertiary referral Brazilian hospital." Anais Brasileiros de Dermatologia. 2025. View Study
9. Poudel RR, Belbase B, Kafle NK. "Nummular eczema." Journal of Community Hospital Internal Medicine Perspectives. 2015. View Study
10. Borda LJ, Wikramanayake TC. "Seborrheic Dermatitis and Dandruff: A Comprehensive Review." Journal of Clinical and Investigative Dermatology. 2015. View Study
11. Raffetto JD, Ligi D, Maniscalco R, Khalil RA, Mannello F. "Why Venous Leg Ulcers Have Difficulty Healing: Overview on Pathophysiology, Clinical Consequences, and Treatment." Journal of Clinical Medicine. 2021. View Study
12. Ju T, Vander Does A, Mohsin N, Yosipovitch G. "Lichen Simplex Chronicus Itch: An Update." Acta Dermato-Venereologica. 2022. View Study
13. Lee EJ, Kim JH, Choi HG, Kang HS, Lim H, Kim JH, Cho SJ, Nam ES, Park HY, Kim NY, Kwon MJ. "Comparison of the Concordance of Allergic Diseases between Monozygotic and Dizygotic Twins: A Cross-Sectional Study Using KoGES HTS Data." Journal of Personalized Medicine. 2023. View Study
14. Matwiejuk M, Kulczyńska-Przybik A, Myśliwiec H, Mikłosz A, Chabowski A, Mroczko B, Flisiak I. "The role of chemerin, elafin, and visfatin in the pathogenesis of atopic dermatitis." Frontiers in Immunology. 2025. View Study
15. Lee DG, Gui XY, Mukovozov I, Fleming P, Lynde C. "Sleep Disturbances in Children With Atopic Dermatitis: A Scoping Review." Journal of Cutaneous Medicine and Surgery. 2023. View Study
16. Piacentini F, Camera E, Di Nardo A, Dell'Anna ML. "Seborrheic Dermatitis: Exploring the Complex Interplay with Malassezia." International Journal of Molecular Sciences. 2025. View Study
17. Victoire A, Magin P, Coughlan J, van Driel ML. "Interventions for infantile seborrhoeic dermatitis (including cradle cap)." Cochrane Database of Systematic Reviews. 2019. View Study
18. Lugović-Mihić L, Bukvić I, Bulat V, Japundžić I. "Factors Contributing to Chronic Urticaria/Angioedema and Nummular Eczema Resolution – Which Findings Are Crucial?" Acta Clinica Croatica. 2019. View Study
19. Suzuki NM, Hafner MFS, Lazzarini R, Duarte IAG, Veasey JV. "Patch tests and hand eczema: retrospective study in 173 patients and literature review (nickel/cobalt relevance)." Anais Brasileiros de Dermatologia. 2023. View Study
20. Aleid NM, Fertig R, Maddy A, Tosti A. "Common Allergens Identified Based on Patch Test Results in Patients with Suspected Contact Dermatitis of the Scalp." Skin Appendage Disorders. 2017. View Study
21. Karagounis TK, Cohen DE. "Occupational Hand Dermatitis." Current Allergy and Asthma Reports. 2023. View Study
22. Janßen S, Schmölders J, Jansen TM, Ertas N, Rembe JD, Homey B, Hoff NP. "Intermittent Pneumatic Impulse Compression in the Treatment of Stasis Dermatitis—A Monocenter Randomized Controlled Trial." Journal of Clinical Medicine. 2025. View Study
23. Johnson SM, Roh YS, Rozati S. "A Complex Case of Unilateral Stasis Dermatitis With Id Reaction Misdiagnosed as Cellulitis: A Diagnostic Challenge." Cureus. 2026. View Study
24. Voorberg AN, Loman L, Schuttelaar MLA. "Prevalence and Severity of Hand Eczema in the Dutch General Population: A Cross-sectional, Questionnaire Study within the Lifelines Cohort Study." Acta Dermato-Venereologica. 2022. View Study
25. Bozek A, Zajac M, Krupka M. "Atopic Dermatitis and Psoriasis as Overlapping Syndromes." Mediators of Inflammation. 2020. View Study
26. Youn SW. "Nail Psoriasis: Clinical Features and Severity Assessment." Annals of Dermatology. 2024. View Study
27. Ocampo DV, Gladman D. "Psoriatic arthritis." F1000Research. 2019. View Study
28. Danby SG, Andrew PV, Taylor RN, Kay LJ, Chittock J, Pinnock A, Ulhaq I, Fasth A, Carlander K, Holm T, Cork MJ. "Different types of emollient cream exhibit diverse physiological effects on the skin barrier in adults with atopic dermatitis." Clinical and Experimental Dermatology. 2022. View Study
29. Liu-Walsh F, Tierney NK, Hauschild J, Rush AK, Masucci J, Leo GC, Capone KA. "Prebiotic Colloidal Oat Supports the Growth of Cutaneous Commensal Bacteria Including S. epidermidis and Enhances the Production of Lactic Acid." Clinical, Cosmetic and Investigational Dermatology. 2021. View Study
30. Gooderham MJ, Hong HC, Lynde C, Papp KA, Yeung J, Lui H, Miller-Monthrope Y, Ringuet J, Turchin I, Prajapati VH. "Canadian Consensus Guidelines for the Management of Atopic Dermatitis with Topical Therapies." Dermatology and Therapy. 2025. View Study
31. Carr WW. "Topical Calcineurin Inhibitors for Atopic Dermatitis: Review and Treatment Recommendations." Paediatric Drugs. 2013. View Study
32. Beck LA, Bissonnette R, Deleuran M, et al. "Dupilumab in Adults With Moderate to Severe Atopic Dermatitis: A 5-Year Open-Label Extension Study." JAMA Dermatology. 2024. View Study
33. Wan H, Jia H, Xia T, Zhang D. "Comparative efficacy and safety of abrocitinib, baricitinib, and upadacitinib for moderate-to-severe atopic dermatitis: A network meta-analysis." Dermatologic Therapy. 2022. View Study
34. Kelati A, Gallouj S, Tahiri L, Harmouche T, Mernissi FZ. "Defining the mimics and clinico-histological diagnosis criteria for mycosis fungoides to minimize misdiagnosis." International Journal of Women's Dermatology. 2017. View Study
35. Leung DYM, Berdyshev E, Goleva E. "Cutaneous barrier dysfunction in allergic diseases." Journal of Allergy and Clinical Immunology. 2020;145(6):1485–1497. View Study
36. Siu Kan Law, Yanping Wang, Xiao Xiao Wu. "Comparison of the Effectiveness Differences between Western and Chinese Medicinal Ointments against Eczema." Pharmaceuticals (Basel, Switzerland). 2025. View Study